Riskpilot← Back to searchSign inGet full accessGM MEDICAL A/S
A/SDissolvedCVR 25639375Vejleåvej 66Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20006 employees
Revenue 2024
DKK 8,6M
+21% vs 2023
EBITDA margin
-15.8%
-154% vs 2023
Equity ratio
33.2%
Financial strength
Net profit 2024
DKK -1,4M
-194% vs 2023
| Revenue | DKK 8,6M | +21% |
| EBITDA | DKK -1,4M | -154% |
| Net profit | DKK -1,4M | -194% |
| Total assets | DKK 18,5M | +34% |
| Equity | DKK 6,2M | -18% |
| Employees | 6 | — |
Legal name
GM MEDICAL A/S
CVR number
25639375
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. september 2000
Share capital
DKK 500.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 medlemmer af bestyrelsen i forening eller af en direktør alene.
Address
Vejleåvej 66
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10.010 | 8.934 | 9.320 | 7.120 | 8.598 |
| Staff expenses | -4.526 | -4.791 | -5.109 | -4.288 | -5.397 |
| EBITDA | 5.484 | 4.143 | 4.211 | 2.510 | -1.359 |
| Depreciation & amort. | -168 | -94 | -99 | -74 | -282 |
| EBIT | 5.316 | 4.049 | 4.112 | 2.435 | -1.641 |
| Net financials | 514 | 992 | 699 | -394 | -59 |
| Profit before tax | 5.830 | 5.041 | 4.812 | 2.041 | -1.700 |
| Tax | 1.161 | 922 | 904 | 512 | -262 |
| Net profit | 4.669 | 4.119 | 3.907 | 1.529 | -1.438 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 24.193 | 19.379 | 17.459 | 13.786 | 18.535 |
| Equity | 8.127 | 8.270 | 9.108 | 7.481 | 6.155 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16.066 | 11.093 | 8.312 | 6.248 | 12.259 |
| Total debt | 16.066 | 11.093 | 8.312 | 6.248 | 12.259 |
EBITDA margin
-15.8%
This company
15.8%
Market median
-200% vs market
20202024
Equity ratio
33.2%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
-23.4%
This company
18.4%
Market median
-227% vs market
20202024
Net profit margin
-16.7%
This company
8.1%
Market median
-306% vs market
20202024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20202024
Debt / equity
2.01×
This company
0.62×
Market median
-224% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
CF Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
SG Chief Executive Officer | Chief Executive Officer | 2000 – 2005 |
JA Chief Executive Officer | Chief Executive Officer | 2005 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (12) | ||
| Chairman | 2023 – 2025 | |
| Board of Directors | 2005 – 2009 | |
| Chairman | 2011 – 2014 | |
| Chairman | 2005 – 2011 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2000 – 2005 | |
| Board of Directors | 2018 – 2018 | |
| Board of Directors | 2014 – 2015 | |
| Chairman | 2000 – 2005 | |
| Board of Directors | 2011 – 2018 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 25–33.32% | 2018 | |
| Individual | 50–66.65% | 50–66.65% | 2005 | |
| Company | 10–14.99% | 10–14.99% | 2018 | |
| Company | 100% | 100% | 2023 | |
| Individual | 10–14.99% | 10–14.99% | 2010 | |
| Individual | 10–14.99% | 10–14.99% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GM MEDICAL A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cindy Fugleholm Nijs | Chief Executive Officer | 0 companies |
| Søren Grøndorf | Chief Executive Officer | 0 companies |
| Jesper Anker Fremming | Chief Executive Officer | 0 companies |
| Peter Bo Soelberg | Chairman | 0 companies |
| Jesper Fruelund Schmidt | Board of Directors | 0 companies |
| Jens Gerlif | Chairman | 0 companies |
| Karsten Kielland | Chairman | 0 companies |
| John Robert Morrison | Board of Directors | 0 companies |
| Vibeke Grøndorf | Board of Directors | 0 companies |
| Jesper Juul | Board of Directors | 0 companies |
| Henrik Lasthein | Board of Directors | 0 companies |
| Niels-Vagn Falling Olsen | Chairman | 0 companies |
| Fredrik Greftegreff | Board of Directors | 0 companies |
| Philip Michael Walker | Board of Directors | 0 companies |
| Brian Vester | Board of Directors | 0 companies |